Infertility is a global challenge, often remedied with In vitro fertilization (IVF) and Intra cytoplasmic sperm injection (ICSI). Sperm quality is crucial, prompting ICSI when compromised. Routine sperm preparation via gradient centrifugation raises concerns about sperm stress and DNA fragmentation. Zymot, a new device that utilizes microfluidic technology, emerges as a promising alternative. It minimizes sperm stress and DNA damage, potentially enhancing fertilization rates and embryo quality. The aim of this study was to compare the outcome of ICSI samples treated with Zymot against gradient centrifuged samples. Focus was on fertilization rates, embryo quality, and pregnancy outcomes.  The results of 104 Zymot treated samples from men with compromised sperm quality were compared with 144 gradient centrifugations retrospective. Results revealed a significant difference between methods in the number of pronulear (PN), specifically in the Good Quality Embryo (GQE) where 62% with Zymot were 2PN compared to 59% with gradient (p=0.017). No significant difference in pregnancy rates or embryo utilization rate were observed. A tendency towards higher proportion (54.6%) of Zymot-treated embryos were cryopreserved compared to gradient (49.4%, p=0,27). In conclusion, a significant difference between methods in the GQE proportion of 2PN embryos favored Zymot. Closer examination revealed a higher proportion of embryos cryopreserved with Zymot, suggesting a potential for increased treatment success in future cycles. Zymot, requiring less time, yielded equivalent results to gradient centrifugation, with higher GQE proportions and more embryos cryopreserved. This merits consideration as a high-quality alternative to sperm preparation for ICSI in cases of poor sperm quality.